Performance and image enhancing drug injecting in Australia

澳大利亚注射毒品提高表现和形象

• 批准号: DP170100302
• 负责人: Prof Suzanne Fraser
• 金额: $ 33.06万
• 依托单位: La Trobe University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2020-08-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP170100302
• 关键词: Performance; image; enhancing; drug; injecting

This project aims to research the use of performance and image-enhancing drugs (PIED), to understand the associated social practices and to assess what health information PIED injectors need. PIEDs use is increasing in Australia and is associated with serious health issues, including the transmission of blood-borne viruses, especially hepatitis C (HCV). Little is known about PIED injecting and the nation's harm reduction framework is unprepared to meet the problems it poses. This project expects to directly inform policy and practice, potentially averting an epidemic of HCV in this population, and aims to minimise HCV transmission among people who inject PIEDs.

该项目旨在研究绩效和图像增强药物(PIED)的使用，了解相关的社会实践，并评估PIED注射者需要哪些健康信息。在澳大利亚，花生的使用正在增加，并与严重的健康问题有关，包括血液传播病毒的传播，特别是丙型肝炎(丙型肝炎)。人们对Ped注射知之甚少，而且国家的减少伤害框架也没有准备好应对它带来的问题。该项目希望直接为政策和实践提供信息，潜在地避免丙型肝炎病毒在该人群中的流行，并旨在将丙型肝炎病毒在注射PIED的人中的传播降至最低。